SAM
ANIK icon

Smartleaf Asset Management’s Anika Therapeutics ANIK Stock Holding History

Smartleaf Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.8K Buy
1,261
+610
+94% +$7.08K ﹤0.01% 2023
2025
Q4 		$6.22K Buy
651
+540
+486% +$5.17K ﹤0.01% 2613
2025
Q3 		$1.01K Buy
111
+67
+152% +$640 ﹤0.01% 2745
2025
Q2 		$472 Buy
+44
New +$555 ﹤0.01% 2598
2025
Q1 		– Sell
-21
Closed -$341 – 2867
2024
Q4 		$341 Sell
21
-150
-88% -$2.96K ﹤0.01% 2827
2024
Q3 		$4.2K Buy
171
+72
+73% +$1.87K ﹤0.01% 2197
2024
Q2 		$2.55K Buy
+99
New +$2.57K ﹤0.01% 2130

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Smartleaf Asset Management's ANIK Position: Q1 2026 in Review

Smartleaf Asset Management increased its Anika Therapeutics (ANIK) stake by 94% in Q1 2026, buying an estimated $7.08K and bringing the position to 1,261 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2023.

Smartleaf Asset Management first reported a position in ANIK in Q2 2024 and has held it in 7 quarters since. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Smartleaf Asset Management held 1,261 shares of Anika Therapeutics worth $17.8K as of Q1 2026.
  • Smartleaf Asset Management bought 610 Anika Therapeutics shares in Q1 2026, an estimated $7.08K.
  • Anika Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2023 holding.
  • Smartleaf Asset Management first reported a position in Anika Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.